BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING

BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING is registered as a foundation with organisation number 930517364. The business is classified under activities of charities which distribute means themselves (NACE 94.991). The company was incorporated in 2022. Registered share capital is NOK 2.6m. The most recent filed accounts, for the 2025 financial year, show NOK 27,000 in revenue and NOK 12,000 in operating profit.

Key figures · 2025

Revenue

NOK 27,000

Operating profit

NOK 12,000

Equity

NOK 333,000

Est. value

NOK 213,000

Financial health · 2025

Liquidity

–

Not available

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

100.0%

Very good

Equity as a share of total capital

Who owns BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING?

No shareholders are registered for BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING in open Norwegian sources. Shareholder data exists mainly for limited companies (AS/ASA).

Frequently asked questions about BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING

What is the revenue of BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING?

BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING had revenue of NOK 27,000 in 2025.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.